PBLS 8-K 2026-09-02

Parabilis Medicines, Inc. (PBLS) 8-K dated 2026-09-02 — accession 0001193125-26-380171.

Parabilis Medicines, Inc. (PBLS) common stock.

Parabilis Medicines, Inc. filed a 8-K on 2026-09-02. Accession 0001193125-26-380171.

This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.

Latest reported PBLS revenue for 2026-06-30 was $148.0K. Net income was -$52.5M.

Not investment advice. The PBLS SEC hub lists recent forms. The stock page is the research view.